How the GAP Program Helps Determine Patient Prognosis, and Risk Factors for Developing IPF/PPF

Opinion
Video

Paul Noble, MD, analyzes variables contributing to IPF or PPF disease prognosis.

Video content above is prompted by the following:

  • How can a GAP (gender/age physiology) help determine patient prognosis with IPF or PPF?
  • What are the risk factors for developing IPF or PPF and can patients be screened for the disease?
Related Videos
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Video 5 - "Obstacles in Adapting Diabetes Technology to Individual Needs" - 1 KOL is featured
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Video 4 - "The Impact of Continuous Glucose Monitors & Digital Solutions on Diabetes Care"
Video 3 - "The Pivotal Role of Patient Engagement and Education in Achieving Optimal Diabetes Outcomes"
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Lawrence Eichenfield, MD, an expert on atopic dermatitis
© 2024 MJH Life Sciences

All rights reserved.